Eddit

Aus coViki
(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
 
(103 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 1: Zeile 1:
 
__NOTOC__
 
__NOTOC__
 
*'''[[Further reading]]'''
 
*'''[[Further reading]]'''
 +
  
 
*'''[[Unproven ideas]]'''
 
*'''[[Unproven ideas]]'''
{{tp|p=32311318|t=ä. SARS-CoV-2 and ''viral sepsis'': observations and hypotheses |pdf=|usr=}}
 
{{tp|p=32325026|t=2020. Endothelial cell infection and endotheliitis in COVID-19 |pdf=|usr=}}
 
  
 
*'''[[Reviews on covid19 disease]]'''
 
*'''[[Reviews on covid19 disease]]'''
 
 
*'''[[Clinical guidelines and advice]]'''
 
*'''[[Clinical guidelines and advice]]'''
{{tp|p=32360205|t=ä. What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?|pdf=|usr=}}
 
{{tp|p=32336069|t=2020. What should a cardiologist know about coronavirus disease 2019?|pdf=|usr=}}
 
  
----
 
  
  
*'''[[Structure of covid19]]'''
+
*'''[[Respiration mgmt]]'''
{{tp|p=32350227|t=2020. Characteristics of SARS-CoV-2 isolated from asymptomatic carrier in Tokyo |pdf=|usr=}}
+
{{tp|p=32007145|t=2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding |pdf=|usr=}}
+
  
 +
*'''[[Diagnosis (Laboratory)]]'''
  
 +
 +
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 +
 +
*'''[[Diagnosis (other modalities)]]'''
 +
 +
 +
 +
 +
*'''[[Structure of covid19]]'''
  
  
 
*'''[[Target binding and uptake]]'''
 
*'''[[Target binding and uptake]]'''
 
*'''[[Cytopathic effects]]'''
 
*'''[[Cytopathic effects]]'''
 
 
*'''[[Secretion and shedding]]'''
 
*'''[[Secretion and shedding]]'''
{{tp|p=32304647|t=2020. SARS-CoV-2 shedding and infectivity |pdf=|usr=}}
 
{{tp|p=32304646|t=ä. SARS-CoV-2 shedding and infectivity ? Authors  reply |pdf=|usr=}}
 
  
  
Zeile 34: Zeile 34:
  
 
*'''[[Immunology]]'''
 
*'''[[Immunology]]'''
{{tp|p=32213336|t=ä. SARS-CoV-2: virus dynamics and host response |pdf=|usr=}}
 
{{tp|p=32213337|t=ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort  study |pdf=|usr=}}
 
  
 
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
 
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
  
----
 
  
  
 +
*'''[[Pathobiology]]'''
  
  
*'''[[Early symptoms]]'''
+
*'''[[Disease Models]]'''
  
*'''[[Systemic disease, any manifestations]]'''
 
  
*'''[[Co-Infection]]'''
+
*'''[[Similar diseases and pathomechanisms]]'''
{{tp|p=32307254|t=ä. Invasive fungal diseases during COVID-19: We should be prepared |pdf=|usr=}}
+
{{tp|p=32297939|t=ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise |pdf=|usr=}}
+
{{tp|p=32293646|t=ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens |pdf=|usr=}}
+
  
  
*'''[[ARDS]]'''
 
  
*'''[[Pulmonary embolism, coagulation]]'''
 
{{tp|p=32330428|t=ä. Hospital-based use of thromboprophylaxis in patients with COVID-19 |pdf=|usr=}}
 
  
 +
*'''[[Early symptoms]]'''
  
 +
*'''[[Systemic disease, any manifestations]]'''
  
*'''[[Hematology]]'''
+
*'''[[Co-Infection]]'''
  
*'''[[Microvascular]]'''
 
  
*'''[[Heart]]'''
+
*'''[[Pulmonary embolism, coagulation]]'''
{{tp|p=32334650|t=ä. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes |pdf=|usr=}}
+
  
*'''[[Neurology, ophthalmology, orl]]'''
 
{{tp|p=32320008|t=ä. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection |pdf=|usr=}}
 
{{tp|p=32275288|t=ä. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019  in Wuhan, China |pdf=|usr=}}
 
{{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}}
 
  
*'''[[Dermatology]]'''
 
  
  
*'''[[Gastroenterology, hepatology]]'''
 
*'''[[Kidney, urology]]'''
 
----
 
  
 +
*'''[[Hematology]]'''
  
*'''[[Pathobiology]]'''
 
  
  
 +
*'''[[Heart]]'''
  
*'''[[Disease Models]]'''
 
  
*'''[[Similar diseases and pathomechanisms]]'''
 
{{tp|p=32370951|t=ä. Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic |pdf=|usr=}}
 
  
----
+
*'''[[Neurology, ophthalmology, orl]]'''
  
  
*'''[[Diagnosis (Laboratory)]]'''
 
  
 +
*'''[[Dermatology]]'''
  
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
  
*'''[[Diagnosis (other modalities)]]'''
 
{{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
 
  
 +
*'''[[Gastroenterology, hepatology]]'''
  
*'''[[Respiration mgmt]]'''
+
*'''[[Kidney, urology]]'''
{{tp|p=32340627|t=2020. Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic |pdf=|usr=}}
+
  
 +
*'''[[The morbid survivor]]'''
  
 
*'''[[Risk and special populations]]'''
 
*'''[[Risk and special populations]]'''
Zeile 110: Zeile 89:
  
  
*'''[[The morbid survivor]]'''
+
*'''[[Case reports]]'''
{{tp|p=32219356|t=ä. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
+
 
{{tp|p=32369030|t=2020. Considerations for Postacute Rehabilitation for Survivors of COVID-19 |pdf=|usr=}}
+
{{tp|p=32333842|t=2020. The key role of palliative care in response to the COVID-19 tsunami of suffering |pdf=|usr=}}
+
  
  
  
  
*'''[[Case reports]]'''
 
  
  
 
*'''[[Case series]]'''
 
*'''[[Case series]]'''
 +
  
 
*'''[[Registries]]'''
 
*'''[[Registries]]'''
{{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
 
 
 
----
 
  
  
 
*'''[[Trials]]'''
 
*'''[[Trials]]'''
{{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
 
{{tp|p=32363333|t=ä. A real-time dashboard of clinical trials for COVID-19 |pdf=|usr=}}
 
  
 
*'''[[Candidate Compounds Covid19]]'''
 
*'''[[Candidate Compounds Covid19]]'''
 
----
 
 
*'''[[Remission, recurrence and persistence]]'''
 
{{tp|p=32303482|t=ä. Re-emergence of SARS-CoV2 in a discharged COVID-19 case |pdf=|usr=}}
 
{{tp|p=32299784|t=ä. How do we decide to de-isolate COVID-19 patients?|pdf=|usr=}}
 
{{tp|p=32105304|t=2020. Positive RT-PCR Test Results in Patients Recovered From COVID-19 |pdf=|usr=}}
 
 
  
  
 
*'''[[Other routes of infection]]'''
 
*'''[[Other routes of infection]]'''
{{tp|p=32276848|t=ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease  2019 |pdf=|usr=}}
 
{{tp|p=32224116|t=ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?|pdf=|usr=}}
 
{{tp|p=32035510|t=2020. 2019-nCoV transmission through the ocular surface must not be ignored |pdf=|usr=}}
 
{{tp|p=32199469|t=2020. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples |pdf=|usr=}}
 
  
  
 
*'''[[Biophysics of aerosols]]'''
 
*'''[[Biophysics of aerosols]]'''
{{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
+
 
{{tp|p=32360356|t=ä. Putting some context to the aerosolization debate around SARS-CoV-2 |pdf=|usr=}}
+
 
  
  
 
*'''[[Passive protective equipment]]'''
 
*'''[[Passive protective equipment]]'''
{{tp|p=32129805|t=2020. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient |pdf=|usr=}}
 
  
*'''[[Running your hospital]]'''
 
  
  
----
+
*'''[[Running your hospital]]'''
  
  
 
*'''[[Mental aspects of health professionals]]'''
 
*'''[[Mental aspects of health professionals]]'''
 +
 
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
 
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
 +
 +
  
  
 
*'''[[Avoiding clinical medicine in other diseases]]'''
 
*'''[[Avoiding clinical medicine in other diseases]]'''
{{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations  in the United States during COVID-19 Pandemic |pdf=|usr=}}
+
 
  
  
 
*'''[[Occupational medicine, workplace security and status hygienicus]]'''
 
*'''[[Occupational medicine, workplace security and status hygienicus]]'''
 +
 +
 
*'''[[Economic aspects of the status hygienicus]]'''
 
*'''[[Economic aspects of the status hygienicus]]'''
{{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
 
{{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
 
{{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
 
{{tp|p=32048740|t=2020. Economic impacts of Wuhan 2019?nCoV on China and the world |pdf=|usr=}}
 
{{tp|p=32311326|t=ä. COVID-19 disrupts vaccine delivery |pdf=|usr=}}
 
  
  
Zeile 188: Zeile 145:
  
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
{{tp|p=31967321|t=2020. Cross?species transmission of the newly identified coronavirus 2019?nCoV |pdf=|usr=}}
 
{{tp|p=32346658|t=ä. SARS-CoV-2 and Bats: From Flight to Fighting COVID-19 |pdf=|usr=}}
 
  
 
*'''[[Origin of Covid19]]'''
 
*'''[[Origin of Covid19]]'''
{{tp|p=32277970|t=ä. Strategies to trace back the origin of COVID-19 |pdf=|usr=}}
 
  
 +
*'''[[Epidemiology]]'''
  
  
*'''[[Epidemiology]]'''
 
  
  
*'''[[Failure of politics and public health guidance]]'''
+
 
 +
*'''[[Remission, recurrence and persistence]]'''
 +
 
  
  
 
*'''[[Failure of executive measures]]'''
 
*'''[[Failure of executive measures]]'''
 
----
 
----
 +
*'''[[Failure of politics and public health guidance]]'''
  
  
 
*'''[[Political abuse of Covid19]]'''
 
*'''[[Political abuse of Covid19]]'''
 
  
  
  
 
*'''[[Lost people]]'''
 
*'''[[Lost people]]'''
 
  
 
*'''[[Lost civilization]]'''
 
*'''[[Lost civilization]]'''
 +
 
----
 
----
  
  
 
*'''[[History of covid19 exploration]]'''
 
*'''[[History of covid19 exploration]]'''
 +
*'''[[misc.]]'''
  
  
*'''[[misc.]]'''
+
*'''[[Research tools]]'''
  
  
  
  
*'''[[Research tools]]'''
+
{{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}}
{{tp|p=C7118609|t=ä. NetNCSP: Nonoverlapping closed sequential pattern mining |pdf=|usr=}}
+
{{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}}
 +
 
 +
 
 +
*'''[[PrePrint scene]]'''
  
  
 
*'''[[from the ads]]'''
 
*'''[[from the ads]]'''
*[lifechemicals.com antiviral candidate drugs]
 
*[biomol.com assays cytokines general spectrum]
 
*[labospace.com custom single probe assay 400 possible cytokines and so on]
 
*[codexdna.com dna synthesis]
 
*
 
  
 
*'''[[Current state of coviki.org]]'''
 
*'''[[Current state of coviki.org]]'''
 +
*'''[[on-topic personal thoughts]]'''

Aktuelle Version vom 7. Juni 2020, 22:19 Uhr



















































27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
25040500 2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system



Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis